1FOL
REDUCED BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME DOMAIN COMPLEXED WITH L-ARG(H4B-FREE)
1FOL の概要
エントリーDOI | 10.2210/pdb1fol/pdb |
関連するPDBエントリー | 4NSE |
分子名称 | NITRIC-OXIDE SYNTHASE, CACODYLATE ION, ACETATE ION, ... (8 entities in total) |
機能のキーワード | alpha-beta fold, nitric oxide synthase, oxidoreductase |
由来する生物種 | Bos taurus (cattle) |
細胞内の位置 | Cell membrane: P29473 |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 101737.36 |
構造登録者 | Raman, C.S.,Li, H.,Martasek, P.,Masters, B.S.,Poulos, T.L. (登録日: 2000-08-28, 公開日: 2001-07-20, 最終更新日: 2024-02-07) |
主引用文献 | Li, H.,Raman, C.S.,Martasek, P.,Masters, B.S.,Poulos, T.L. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors Biochemistry, 40:5399-5406, 2001 Cited by PubMed Abstract: The crystal structure of the endothelial nitric oxide synthase (NOS) heme domain complexed with NO reveals close hydrogen bonding interactions between NO and the terminal guanidino nitrogen of the substrate, L-arginine. Dioxygen is expected to bind in a similar mode which will facilitate proton abstraction from L-Arg to dioxygen, a required step for O-O bond cleavage. Structures of mechanism-based NOS inhibitors, N(5)-(1-iminoethyl)-L-ornithine and N-(3-(aminomethyl)benzyl)acetamidine, provide clues on how this class of compounds operate as suicide substrate inhibitors leading to heme oxidation. PubMed: 11331003DOI: 10.1021/bi002658v 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.2 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード